Search by Drug Name or NDC
NDC 17156-0024-05 Myoview 0.23 mg/1 Details
Myoview 0.23 mg/1
Myoview is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Medi-Physics Inc. dba GE Healthcare. The primary component is TETROFOSMIN.
Product Information
| NDC | 17156-0024 |
|---|---|
| Product ID | 17156-024_cfb49f93-c931-4429-8a04-d3c6d1e913a0 |
| Associated GPIs | 94353080756400 |
| GCN Sequence Number | 062764 |
| GCN Sequence Number Description | kit for prep Tc-99m/tetrofosmn VIAL 0.23 MG INTRAVEN |
| HIC3 | A6W |
| HIC3 Description | CARDIOVASCULAR DIAGNOSTICS - RADIOACTIVE |
| GCN | 98538 |
| HICL Sequence Number | 024544 |
| HICL Sequence Number Description | KIT FOR THE PREPARATION OF TC-99M/TETROFOSMIN |
| Brand/Generic | Brand |
| Proprietary Name | Myoview |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tetrofosmin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.23 |
| Active Ingredient Units | mg/1 |
| Substance Name | TETROFOSMIN |
| Labeler Name | Medi-Physics Inc. dba GE Healthcare |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020372 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 17156-0024-05 (17156002405)
| NDC Package Code | 17156-024-05 |
|---|---|
| Billing NDC | 17156002405 |
| Package | 5 VIAL in 1 KIT (17156-024-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| Marketing Start Date | 2022-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |